Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

NCT00406315 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

255

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: ziprasidone

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.